GRACE
A

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologists Determine Treatment

By GRACE FEATURING Aaron Goodman, Autumn Jeong, Sridevi Rajeeve
June 30, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

14:41
Sanofi

Efficacy and Safety of a Treatment Option for Adults with Multiple M…

Feat. J. Mikhael

Featured Video

15:52
Lilly

BTK Inhibition for Patients with MCL: Safety and Efficacy Data

Feat. J. Pagel

Related Content

AUTOPLAY
20:19
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …

Feat. A. Paulus
12:38
SOHO 2022 Tenth Annual Meeting

SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…

Feat. S. Usmani
14:09
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Multiple Myeloma Highlights and Clinical P…

Feat. H. Hashmi
04:08
GRACE

CAR T-Cell Therapy Side Effects for Blood Cancers

Feat. A. Goodman
31:51
Indy Hematology Review

Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…

Feat. K. Anderson
15:24
Michael Soulen

Interventional Delivery of CAR-T Therapy

03:17
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Highlights From the International Myeloma S…

Feat. J. Richter
07:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…

Feat. L. Shune
44:49
Dana-Farber Cancer Institute

Recent Updates in Multiple Myeloma

Feat. K. Anderson
32:03
Indy Hematology Review

Emerging and Current Treatment of MM: What Should We Know and What S…

Feat. K. Anderson
32:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Improbable History of CAR T-Cells

Feat. C. June
18:27
Indy Hematology Review

DEBATE: Why Not to Transplant When MRD Has Been Achieved After Initi…

Feat. J. Mikhael
25:24
Beth Israel Deaconess Medical Center

CAR T-Cell Failure: Mechanisms and Salvage Options

Feat. J. Arnason
30:59
Houston Methodist Hospital

Overview of Advances in Multiple Myeloma

Feat. S. Ganguly
26:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Bispecifics in Multiple Myeloma

Feat. P. Mangan
20:50
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Multiple Roadblocks to Access for CAR-T in MM: Optimizing Road C…

Feat. K. Patel
17:34
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Overview and Updates in CAR-T for Multiple Myeloma

Feat. E. Stadtmauer
26:24
Dana-Farber Cancer Institute

Myeloma 101: Diagnosis, Prognosis & Risk

Feat. N. Munshi
13:52
Parva Bhatt

Sequencing BCMA Directed Therapy in R/R MM

20:11
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Combination Therapy Trials in Myeloma - A …

Feat. A. Jakubowiak